Serum JKAP as a potential prognostic biomarker in acute coronary syndrome patients undergoing percutaneous coronary intervention
Xinjing Chen, Jingxuan Hong · 2025
Read Serum JKAP as a potential prognostic biomarker in acute coronary syndrome patients undergoing percutaneous coronary intervention by Xinjing Chen, Jingxuan Hong (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12741847.txt.
Description
Xinjing Chen and Jingxuan Hong test a blood protein as a forecasting marker for heart patients who had artery-opening treatment, in work from 2025. The protein reins in a cell signal path and shapes immune cell balance. Prior work tied its loss to worse artery disease.
The study held 173 patients with acute coronary syndrome and thirty-two healthy adults. Protein levels ran lower in patients than in healthy adults, then rose a month after treatment. Higher levels went with fewer of one inflammatory T cell kind. The team also tracked fitness scores and major heart events after care. They propose the protein as a cheap aid for judging outlook in this group.
Catalog record
| CREATOR | Xinjing Chen, Jingxuan Hong |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |